Why ThermoGenesis (THMO) Shares Are Down 40%
Why ThermoGenesis (THMO) Shares Are Down 40%
ThermoGenesis Holdings Inc (NASDAQ:THMO) shares are trading lower by 41% to $0.33 during Wednesday's session after the Nasdaq denied the company's request for continued listing and the stock will be suspended at the opening of business on June 17.
ThermoGenesis Holdings Inc（納斯達克：THMO）股票正在週三交易中下跌41％至0.33美元，此前納斯達克拒絕了該公司繼續上市的要求，該股將在6月17日開盤時被暫停交易。納斯達克拒絕了該公司的繼續上市請求並且該股將在6月17日開盤時停牌。
What Happened?
發生了什麼？
On April 19, ThermoGenesis was notified by Nasdaq that its stockholders' equity did not meet the minimum $2.5 million required for continued listing. As of the report date, the company also did not meet alternative Nasdaq requirements for market value or net income.
4月19日，納斯達克通知ThermoGenesis，其股東權益未達到繼續上市所需的最低250萬美元。截至報告期，該公司也未滿足Nasdaq其他市值或淨收益要求。
On June 6 Nasdaq denied the company's request for continued listing, citing a lack of a definitive plan for compliance. As a result, trading of the company's stock will be suspended on June 17 and its securities will be delisted.
在6月6日，納斯達克拒絕了該公司的繼續上市請求，稱其未有達到合規的明確計劃。因此，該公司股票的交易將在6月17日暫停，其證券將被除牌。
The company can appeal this decision by June 13, for a fee of $20,000 but currently does not plan to do so. If no appeal is made, the company's stock is expected to trade on the Over-the-Counter Market (OTC), pending FINRA approval, although this is not guaranteed.
該公司可以在6月13日之前申請上訴，申請費爲20,000美元，但目前並無此打算。如果沒有上訴，該公司的股票有望在場外交易（OTC），該交易還需經過金融行業監管局的批准，儘管這並不保證。
Oracle Misses Q4 Earnings — Stock Surges On Booming AI Demand, OpenAI Contract, Partnership With Google And More
甲骨文錯過Q4盈利-股票因人工智能需求旺盛、與OpenAI合同和與谷歌的合作而飆升
According to data from Benzinga Pro, THMO has a 52-week high of $1.82 and a 52-week low of $0.36.
據Benzinga Pro的數據顯示，THMO的52周最高價爲1.82美元，52周最低價爲0.36美元。
譯文內容由第三人軟體翻譯。